TrialInvestigational new drugs2011
A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction.
Juan W Valle et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
80 papers cite itlatest 60 shown
this papercites it